Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder

Journal of Urology

Volumn 191, Issue 3, 2014, Pages 814-822

  Domingos Pereira, Sonia ^a   Derré, Laurent ^a   Warpelin Decrausaz, Loane ^a   Haefliger, Jacques Antoine ^a   Romero, Pedro ^b   Jichlinski, Patrice ^a   Nardelli Haefliger, Denise ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

CD8 positive T lymphocytes; drug administration routes; immunotherapy; urinary bladder; urinary bladder neoplasms

Indexed keywords

CD8-POSITIVE T-LYMPHOCYTES; DRUG ADMINISTRATION ROUTES; IMMUNOTHERAPY; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

ANIMALS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNIZATION; MICE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS VACCINES; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

ADJUVANT E7 POLYPEPTIDE; GAMMA INTERFERON; PROTEIN E7; TETRAMER; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLADDER TUMOR; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER INFILTRATION; CANCER MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ADMINISTRATION ROUTE; FEMALE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR REGRESSION;

EID: 84893832771     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.08.009     Document Type: Article

References (30)

1. Z. Kirkali, T. Chan, and M. Manoharan et al. Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 66 2005 4
2. M. Babjuk, W. Oosterlinck, and R. Sylvester et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997
3. D.R. Yates, and M. Roupret Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy World J Urol 29 2011 415
4. P. Sharma, Y. Shen, and S. Wen et al. Cancer-testis antigens: expression and correlation with survivalin human urothelial carcinoma Clin Cancer Res 18 2006 5442
5. E.A.M. Shenk-Braat, and C.H. Bangma Immunotherapy for superficial bladder cancer Cancer Immunol Immunother 54 2005 414
6. P. Sharma, D.F. Bajorin, and A.A. Jungbluth et al. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF J Immunother 9 2008 849
7. I. Honma, H. Kitamura, and T. Torigoe et al. Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer Cancer Immunol Immunother 58 2009 1801
8. M.A. Morse, D.A. Bradley, and T. Keler et al. CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer Expert Rev Vaccines 10 2011 733
9. J.C. Nolz, G.R. Starbeck-Miller, and J.T. Harty Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions Immunotherapy 3 2011 1223
10. A. Trinchieri, A. Braceschi, and D. Tiranti et al. Secretory immunoglobulin A and inhibitory activity of bacterial adherence to epithelial cells in urine form patients with urinary tract infections Urol Res 18 1990 305
11. W.J. Hopkins, J. Elkahwaji, and L.M. Beierle et al. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial J Urol 177 2007 1349
12. J.A. Roberts, M.B. Kaack, and G. Baskin et al. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PAPDG protein J Urol 171 2004 1682
13. B.K. Billips, R.E. Yaggie, and J.P. Cashy et al. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli J Infect Dis 200 2009 263
14. T.V. Poggio, J.L. La Torre, and E.A. Scodeller Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge Can J Microbiol 52 2006 1093
15. L. Decrausaz, V. Revaz, and M. Bobst et al. Induction of human papillomavirus oncogene-specific CD8 T cell effector responses in the genital mucosa of vaccinated mice Int J Cancer 126 2010 2469
16. L. Decrausaz, S. Domingos-Pereira, and M. Duc et al. Parenteral but not mucosal immunization is able to induce regression of human papillomavirus associated genital tumors Int J Cancer 129 2011 762
17. V. Revaz, A. Debonneville, and M. Bobst et al. Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse-transcription-PCR Clin Vacc Immunol 5 2008 757
18. L. Decrausaz, A.R. Goncalves, and S. Domingos-Pereira et al. A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers Int J Cancer 128 2011 2105
19. R.K. Naz Female genital tract immunity: distinct immunological challenges for vaccine development J Reprod Immunol 93 2012 1
20. M. Lindqvist, J. Persson, and K. Thörn et al. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection J Immunol 182 2009 6435
21. A. de Haan, B.J. Haijema, and P. Voorn et al. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration Vaccine 30 2012 4884
22. D. Nardelli-Haefliger, P. Romero, and P. Jichlinski What is the influence of vaccination's routes on the regression of tumors located at mucosal sites? Oncoimmunology 1 2012 242
23. F. Sandoval, M. Terme, and M. Nizard et al. Mucosal imprinting of vaccine-induced CD8+ T cells is crucial to inhibit the growth of mucosal tumors Sci Transl Med 5 2013 172ra20
24. S. Domingos-Pereira, L. Decrausaz, and L. Derre et al. Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice Mucosal Immunol 6 2013 393
25. D. Nardelli-Haefliger, J.C. Dudda, and P. Romero Vaccination route matters for mucosal tumors Sci Transl Med 5 2013 172fs4
26. J.F. Jacobs, S. Nierkens, and C.G. Figdor et al. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? Lancet Oncol 13 2012 e32
27. X. Li, E. Kostareli, and J. Suffner et al. Efficient Treg depletion induces T-cell infiltration and rejection of large tumors Eur J Immunol 40 2010 3325
28. N. Garbi, B. Arnold, and S. Gordon et al. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction J Immunol 172 2004 5861
29. C.Y. Chan, A.L. St John, and S.N. Abraham Mast cell interleukin-10 drives localized tolerance in chronic bladder infection Immunity 38 2013 349
30. L. Decrausaz, C. Pythoud, and S. Domingos-Pereira et al. Intravaginal live attenuated Salmonella increase local anti-tumor vaccine-specific CD8 T cells Oncoimmunology 2 2013